Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein
Open accessAbstract
The matrix (MA) protein of human immunodeficiency virus type 1 (HIV-1) forms an inner coat directly underneath the lipid envelope of the virion. The outer surface of the lipid envelope surrounding the capsid is coated by the viral Env glycoproteins. We report here that the HIV-1 capsid-Env glycoprotein association is very sensitive to minor alterations in the MA protein. The results indicate that most of the MA domain of the Gag precursor, except for its carboxy terminus, is essential for this association. Viral particles produced by proviruses with small missense or deletion mutations in the region coding for the amino-terminal 100 amino acids of the MA protein lacked both the surface glycoprotein gp120 and the transmembrane glycoprotein gp41, indicating a defect at the level of Env glycoprotein incorporation. Alterations at the carboxy terminus of the MA domain had no significant effect on the levels of particle-associated Env glycoprotein or on virus replication. The presence of HIV-1 MA protein sequences was sufficient for the stable association of HIV-1 Env glycoprotein with hybrid particles that contain the capsid (CA) and nucleocapsid (NC) proteins of visna virus. The association of HIV-1 Env glycoprotein with the hybrid particles was dependent upon the presence of the HIV-1 MA protein domain, as HIV-1 Env glycoprotein was not efficiently recruited into virus particles when coexpressed with authentic visna virus Gag proteins.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The self-association of HIV-1 MA, especially its trimerization, is crucial for incorporation of envelope glycoprotein into nascently forming virus particles.
“The self-association of HIV-1 MA, and especially its trimerization, has also been shown to be crucial for the incorporation of envelope glycoprotein into the nascently forming virus particles”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Dorfman et al. 1994
Proper localization of Env at the plasma membrane is critical for its selective incorporation into budding virions, a process mediated by interactions between the gp41 cytoplasmic tail and the MA domain of the Gag protein.
“Proper localization of Env at the plasma membrane is critical for its selective incorporation into budding virions, a process mediated by interactions between gp41 cytoplasmic tail and the MA domain of the Gag protein”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Dorfman et al. 1994
Cites
Göttlinger, H. G., Sodroski, J. G., & Haseltine, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5781 · Cited by 841 · see citing works
Self-citationFäcke, M., Janetzko, A., Shoeman, R. L., & Kräusslich, H. G. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4972-4980.1993 · Cited by 198 · see citing works
Rhee, S. S., & Hunter, E. (1990) · Cell · doi:10.1016/0092-8674(90)90289-q · Cited by 160 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
HIV-1 Gag proteins: diverse functions in the virus life cycle
Freed, E. O. (1998) · Virology · doi:10.1006/viro.1998.9398 · Cited by 717 · see citing works
“However, virions with N-terminal CA mutations often display marked infectivity defects and aberrant core morphology by EM (Jowett et al., 1992; von Poblotzki et al., 1993; Wang and Barklis, 1993; Dorfman et al., 1994a; Reicin et al., 1995, 1996).”
BackgroundInfluentialFunctional association of cyclophilin A with HIV-1 virions
Thali, M., Bukovsky, A., Kondo, E., Rosenwlrth, B., Walsh, C. T., Sodroski, J., & Göttlinger, H. G. (1994) · Nature · doi:10.1038/372363a0 · Cited by 629 · see citing works
Self-citationStructural biology of HIV 1 1Edited by P. E. Wright
Turner, B. G., & Summers, M. F. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2354 · Cited by 470 · see citing works
“…Wang & Barklis, 1993; Wang et al., 1993; Wills et al., 1991; Yuan et al., 1993; Zhou et al., 1994) and interacts with the cytoplasmic tail of TM (Dorfman et al., 1994b; Freed & Martin, 1996; Freed et al., 1994; Freed & Martin, 1995; Mammano et al., 1995; Wang & Barklis, 1993; Wang et al., 1993;…”
BackgroundHIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation
Checkley, M. A., Luttge, B. G., & Freed, E. O. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.042 · Cited by 477 · see citing works
Huang, M., Orenstein, J. M., Martin, M. A., & Freed, E. O. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6810-6818.1995 · Cited by 486 · see citing works
“Mutations in the CA of murine leukemia virus (17, 35, 57), Mason-Pfizer monkey virus (59), and HIV-1 (5, 11, 40, 62) also disrupt virion formation.”
BackgroundHill, C. P., Worthylake, D., Bancroft, D. P., Christensen, A. M., & Sundquist, W. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3099 · Cited by 473 · see citing works
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
Usami, Y., Wu, Y., & Göttlinger, H. (2015) · Nature · doi:10.1038/nature15400 · Cited by 459 · see citing works
Self-citationFreed, E., & Martin, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.341-351.1996 · Cited by 382 · see citing works
“(v) HIV-1 MA facilitated the incorporation of HIV-1 Env into visna virus–HIV-1 chimeric particles (7).”
BackgroundMethodLama, J., Mangasarian, A., & Trono, D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80284-x · Cited by 374 · see citing works
Garoff, H., Hewson, R., & Opstelten, D.-J. E. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1171-1190.1998 · Cited by 359 · see citing works
“Fourth, several reports describe the introduction of point mutations and deletions in the MA coding region of the HIV1, SIV, and MPMV genomes (52, 71, 139, 218, 303).”
BackgroundBraaten, D. C., Franke, E. K., & Luban, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3551-3560.1996 · Cited by 327 · see citing works
“The Gag polyprotein specifically incorporates several viral elements into nascent virions, including viral genomic RNA (33), the env glycoprotein (14, 70), and the pol-encoded enzymes (44, 56).”
BackgroundFreed, E., & Martin, M. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1984-1989.1995 · Cited by 344 · see citing works
“A variety of functions have been proposed for the HIV-1 MA, including roles in virus assembly (2, 14, 36, 47), virus entry (44), nuclear localization (3), and incorporation of envelope glycoproteins into virus particles (6, 45).”
BackgroundResultInfluentialGallay, P., Swingler, S., Aiken, C., & Trono, D. (1995) · Cell · doi:10.1016/0092-8674(95)90488-3 · Cited by 330 · see citing works
Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection
Freed, E. O., Englund, G., & Martin, M. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3949-3954.1995 · Cited by 301 · see citing works
“After the 14-day preculture differentiation period, cells were transferred to 96-well Nunc tissue culture plates (1-67008) at 10(5) cells per well.”
BackgroundMethodFreed, E. O., Orenstein, J. M., Buckler-White, A. J., & Martin, M. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5311-5320.1994 · Cited by 291 · see citing works
“It is possible that reductions in the levels of virion-associated gpl20, which have been observed for other MA mutations (11, 76), affect the infectivity of some of our MA mutants.”
BackgroundRole of the Gag Matrix Domain in Targeting Human Immunodeficiency Virus Type 1 Assembly
Ono, A., Orenstein, J. M., & Freed, E. O. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2855-2866.2000 · Cited by 239 · see citing works
“This latter observation could be the result of several factors: (i) reduced immunoreactivity previously described for amino acid 20 substitutions (33) and for other MA mutants (6, 10), (ii) Pr55 instability, and (iii) increased rate of Pr55 processing, also observed previously for residue 20 mutants (33, 34).”
BackgroundBinding of Human Immunodeficiency Virus Type 1 Gag to Membrane: Role of the Matrix Amino Terminus
Ono, A., & Freed, E. O. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4136-4144.1999 · Cited by 238 · see citing works
“Deletions (9, 48, 52) and single amino acid substitutions (13, 15, 33) in MA can block HIV-1 envelope glycoprotein incorporation into virus particles, and HIV-1 MA has been implicated in early events postinfection (for a review, see reference 11).”
BackgroundEfficient HIV‐1 replication can occur in the absence of the viral matrix protein
Reil, H., Bukovsky, A. A., Gelderblom, H. R., & Göttlinger, H. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2699 · Cited by 241 · see citing works
“In-frame deletions in the MA coding region were generated by recombination of previously described MA mutants (Dorfman et al., 1994).”
BackgroundMethodInfluentialSelf-citationRole of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis
Mammano, F., Ohagen, A., Höglund, S., & Göttlinger, H. G. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4927-4936.1994 · Cited by 254 · see citing works
“Under these conditions, HIV-1 surface glycoprotein shed into the medium is excluded from the virion pellet (8).”
BackgroundSelf-citationMontero, M., van Houten, N. E., Wang, X., & Scott, J. K. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-07 · Cited by 251 · see citing works
“Other functions have been described for CT, including interaction with the viral matrix protein (48, 62, 72, 160, 260), targeting to vesicles (56, 129, 194), as well as interaction with other proteins (15, 102, 152, 171, 252).”
BackgroundFunctional domains of the capsid protein of human immunodeficiency virus type 1
Dorfman, T., Bukovský, A., Öhagen, Å., Höglund, S., & Göttlinger, H. G. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8180-8187.1994 · Cited by 218 · see citing works
“Recent studies have shown that the HIV-1 MA domain is both essential and sufficient for incorporation of the viral envelope glycoprotein into nascent particles (13, 46).”
BackgroundSelf-citationHighly Purified Human Immunodeficiency Virus Type 1 Reveals a Virtual Absence of Vif in Virions
Dettenhofer, M., & Yu, X.-F. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1460-1467.1999 · Cited by 239 · see citing works
“In the case of human immunodeficiency virus type 1 (HIV-1), Env is likely to be incorporated into virions by association of its cytoplasmic tail with the matrix protein (MA) of Gag (12, 14, 15, 20, 61, 62).”
BackgroundWyma, D. J., Jiang, J., Shi, J., Zhou, J., Lineberger, J. E., Miller, M. D., & Aiken, C. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3429-3435.2004 · Cited by 225 · see citing works
Murakami, T., & Freed, E. O. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3548-3554.2000 · Cited by 214 · see citing works
“Evidence for a direct Gag-Env interaction includes the findings that (i) mutations in the HIV-1 MA can block HIV-1 Env incorporation (5, 9, 12, 45) (this incorporation defect can be reversed by pseudotyping virions with heterologous Env glycoproteins containing short CTs or by removing the gp41 CT [9, 12, 26]), (ii) H…”
BackgroundSpearman, P. W., Horton, R., Ratner, L., & Kuli-zade, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6582-6592.1997 · Cited by 204 · see citing works
“In addition to its central role in promoting an interaction with the plasma membrane, other functions which have been attributed to the MA region of HIV-1 Pr55 include incorporation of the viral envelope protein onto the developing particle (12, 15, 40), an essential role in early postentry events of the viral life cy…”
BackgroundDirect interaction between the envelope and matrix proteins of HIV-1
Cosson, P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00964.x · Cited by 211 · see citing works
Lodge, R., Lalonde, J., Lemay, G., & Cohen, É. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.4.695 · Cited by 186 · see citing works
“The ratio of apically to basolaterally releaseding of viral budding (Dorfman et al., 1994; Lodge et al., virions was similar to the levels obtained with envelope-1994). negative viruses.”
ResultAccola, M. A., Höglund, S., & Göttlinger, H. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2072-2078.1998 · Cited by 196 · see citing works
“MA, which has a crucial role in the incorporation of the viral surface glycoproteins (10, 52), remains associated with the host cell-derived lipid envelope of the virion (16).”
BackgroundSelf-citationKondo, E., Mammano, F., Cohen, É. A., & Göttlinger, H. G. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2759-2764.1995 · Cited by 160 · see citing works
“MLV/HIV-p6 (lane 1), MLV/HIV-p6(1-41) (lane 2), and MLV/HIV-p6(1-46) or with the HIV-1 Gag polyprotein expression construct HXBH10-PR(2).”
BackgroundInfluentialSelf-citationWyma, D. J., Kotov, A., & Aiken, C. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9381-9387.2000 · Cited by 182 · see citing works
“Although other retroviruses cannot be pseudotyped by full-length HIV-1 proteins, the MA domain of HIV-1 Gag is sufficient for the incorporation of full-length HIV-1 Env in particles produced from chimeric HIV-1–visna virus Gag proteins (8).”
BackgroundHuman immunodeficiency virus type 1 assembly, release, and maturation
Adamson, C. S., & Freed, E. O. (2007) · Advances in Pharmacology · doi:10.1016/s1054-3589(07)55010-6 · Cited by 179 · see citing works
Mammano, F., Kondo, E., Sodroski, J., Bukovský, A., & Göttlinger, H. G. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3824-3830.1995 · Cited by 157 · see citing works
“We reported previously that the HIV-1 capsidEnv glycoprotein interaction is very sensitive to alterations in the MA domain of the Gag polyprotein (9).”
BackgroundMethodResultInfluentialSelf-citationLodge, R., Göttlinger, H., Gabuzda, D., Cohen, É., & Lemay, G. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4857-4861.1994 · Cited by 172 · see citing works
“Without exception, substitutions and deletions in the p17 matrix protein previously shown to prevent the incorporation of Env glycoprotein (4) caused a nonpolarized distriVOL.”
BackgroundResultInfluentialSelf-citationPaillart, J., & Göttlinger, H. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2604-2612.1999 · Cited by 151 · see citing works
“Consistent with this model, we previously reported that a small deletion termed D16-18, which removes a portion of helix 1 of MA, significantly increases particle assembly both at the plasma membrane and at intracellular membranes (12).”
BackgroundResultInfluentialSelf-citationBorman, A., Quillent, C., Charneau, P., Dauguet, C., & Clavel, F. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2058-2067.1995 · Cited by 162
“Since the Gag MA protein has been shown to be essential for envelope incorporation into particles (8, 39), it is conceivable that an aberrantly organized or folded p55 precursor could hinder the MA-Env interaction at the infected cell surface.”
BackgroundLópez‐Vergès, S., Camus, G., Blot, G., Beauvoir, R., Bénarous, R., & Berlioz‐Torrent, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602941103 · Cited by 147 · see citing works
Braaten, D. C., Aberham, C., Franke, E. K., Yin, L., Phares, W., & Luban, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5170-5176.1996 · Cited by 148 · see citing works
Rizzuto, C. D., & Sodroski, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4847-4851.1997 · Cited by 156 · see citing works
“Second, incorporation of ICAM-1, unlike incorporation of the HIV-1 envelope glycoproteins, might not be constrained by interactions with viral matrix protein (13, 49).”
BackgroundReicin, A., Paik, S., Berkowitz, R., Luban, J., Lowy, I., & Goff, S. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.642-650.1995 · Cited by 155 · see citing works
“MA is thought to play a central role in targeting the Gag precursor protein to the site of assembly on the plasma membrane (10, 41, 45, 52) and is essential for the stable association of the HIV-1 Env glycoprotein with the viral capsid (9, 45, 51).”
BackgroundAssembly and Architecture of HIV
Ganser‐Pornillos, B. K., Yeager, M. J., & Pornillos, O. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0980-9_20 · Cited by 161 · see citing works
“…(Göttlinger et al. 1989 ) , directly mediates contacts between Gag and the plasma membrane (Spearman et al. 1994 ; Zhou et al. 1994 ) , and facilitates incorporation of the envelope proteins into the assembling virion (Yu et al. 1992 ; Dorfman et al. 1994 ; Freed and Martin 1995, 1996 ) (Fig.”
Deml, L., Speth, C., Dierich, M. P., Wolf, H. J., & Wagner, R. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.028 · Cited by 142 · see citing works
Muranyi, W., Malkusch, S., Müller, B., Heilemann, M., & Kräusslich, H. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003198 · Cited by 149 · see citing works
“A direct interaction between MA and Env CT in vitro has been reported [10] and there is strong genetic evidence supporting this interaction [5–8,18].”
BackgroundAnalysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids
Alfadhli, A., Still, A., & Barklis, E. (2009) · Journal of Virology · doi:10.1128/jvi.01197-09 · Cited by 145 · see citing works
Labranche, C. C., Sauter, M. M., Haggarty, B., Vance, P., Romano, J., Hart, T. K., Bugelski, P. J., Marsh, M., & Hoxie, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5217-5227.1995 · Cited by 143 · see citing works
“Finally, it will also be of interest to determine if a mutation at the analogous position in the HIV-1 TM cytoplasmic tail has a similar effect.”
BackgroundInfluentialRole of Matrix in an Early Postentry Step in the Human Immunodeficiency Virus Type 1 Life Cycle
Kiernan, R. E., Ono, A., Englund, G., & Freed, E. O. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4116-4126.1998 · Cited by 131 · see citing works
“These and other results (14, 17, 74) suggested a direct interaction between MA and the long cytoplasmic tail of gp41.”
BackgroundResultGöttlinger, H. G. (2001) · AIDS · doi:10.1097/00002030-200100005-00003 · Cited by 124 · see citing works
Self-citationEgan, M. A., Carruth, L. M., Rowell, J. F., Yu, X., & Siliciano, R. F. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6547-6556.1996 · Cited by 131 · see citing works
“Thus, the Gag precursor protein, which may interact with the cytoplasmic domain of gp41 during virus assembly (3, 8, 28, 31, 35, 49, 50), may prevent the internalization of the Env protein.”
BackgroundInfluentialThe Tale of the Long Tail: the Cytoplasmic Domain of HIV-1 gp41
Postler, T. S., & Desrosiers, R. C. (2012) · Journal of Virology · doi:10.1128/jvi.02053-12 · Cited by 122 · see citing works
Alfadhli, A., Barklis, R. L., & Barklis, E. (2009) · Virology · doi:10.1016/j.virol.2009.02.048 · Cited by 125 · see citing works
“…(gp120/gp41) envelope (Env) protein trimers into virus particles (Yu et al., 1992; Wang and Barklis, 1993; Wang et al., 1993; Facke et al., 1993; Dorfman et al., 1994; Zhou et al., 1994; Mammano et al., 1995; Freed and Martin, 1995, 1996; Zhou and Resh, 1996; Ono et al., 1997, 2000; Ono and…”
Borsetti, A., Öhagen, Å., & Göttlinger, H. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9313-9317.1998 · Cited by 126 · see citing works
“Immunorecognition of the Gag polyprotein by patient sera is frequently impaired even by minor alterations (6), which may explain why only relatively small amounts of the D126-277 Gag precursor were detected.”
BackgroundSelf-citationFitzon, T., Leschonsky, B., Bieler, K., Paulus, C., Schröder, J., Wolf, H. J., & Wagner, R. (2000) · Virology · doi:10.1006/viro.1999.0178 · Cited by 100 · see citing works
Popov, S., Popova, E., Inoue, M., & Göttlinger, H. G. (2008) · Journal of Virology · doi:10.1128/jvi.01912-07 · Cited by 112 · see citing works
Self-citationNef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease
Bukovsky, A., Dorfman, T., Weimann, A., & Göttlinger, H. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1013-1018.1997 · Cited by 106 · see citing works
“The full-length HIV-1 proviral constructs HXB-PR(2) (24) and HXB-gag(2) (16) are identical to the nef-negative HXBH10 infectious clone of HIV-1 (24), except for mutations that inactivate protease (PR) or prevent the expression of the Gag polyprotein Pr55.”
BackgroundMethodSelf-citationColgan, J. D., Yuan, H. E., Franke, E. K., & Luban, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4299-4310.1996 · Cited by 98 · see citing works
“precursor (49, 58), the viral envelope protein (13, 68), and the viral accessory protein Vpr (37, 38, 40, 50).”
BackgroundPrince, J. L., Claiborne, D. T., Carlson, J., Schaefer, M., Yu, T.-W., Lahki, S., Prentice, H., Yue, L., Vishwanathan, S., Kilembe, W., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003041 · Cited by 100 · see citing works
“membrane association of Gag [73,79,80], while the latter is an important structural element involved in formation of the”
BackgroundOno, A., Huang, M. ‐., & Freed, E. O. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4409-4418.1997 · Cited by 91 · see citing works
“MA has been postulated to be involved in a variety of steps in the HIV-1 life cycle, including the targeting and binding of the Gag precursor to the plasma membrane (37, 38), the incorporation of envelope (Env) glycoproteins into virions (5, 10, 11, 36), virus assembly and release (4, 12, 30, 32), and virus entry (29,…”
BackgroundThe Roles of Pol and Env in the Assembly Pathway of Human Foamy Virus
Baldwin, D. N., & Linial, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3658-3665.1998 · Cited by 94 · see citing works
Virus-like particles: designing an effective AIDS vaccine.
Young, K., Mcburney, S. P., Karkhanis, L., & Ross, T. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.024 · Cited by 93 · see citing works
Roy, N. H., Chan, J., Lambelé, M., & Thali, M. (2013) · Journal of Virology · doi:10.1128/jvi.00790-13 · Cited by 89 · see citing works
Mammano, F., Salvatori, F., Indraccolo, S., Rossi, A. D., Chieco-Bianchi, L., & Göttlinger, H. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3341-3345.1997 · Cited by 89 · see citing works
“To provide wild-type HIV-1 Env in trans, we used the mutant HIV-1 proviral clone HXBH10-gag(2) (4), which is unable to express internal struc* Corresponding author.”
BackgroundMethodInfluentialSelf-citationHermida-Matsumoto, L., & Resh, M. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1902-1908.1999 · Cited by 95 · see citing works
“In addition to plasma membrane binding, the functional properties of Pr55 responsible for the production of an infectious virion include recruitment of the HIV-1 genome and specific viral proteins into budding virions and processing by HIV-1 protease to generate the structural proteins of the mature virus (8, 17, 18,…”
BackgroundHIV-1 matrix protein binding to RNA
Alfadhli, A., McNett, H., Tsagli, S., Bächinger, H. P., Peyton, D. H., & Barklis, E. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.063 · Cited by 87 · see citing works
Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17
Cannon, P. M., Matthews, S., Clark, N., Byles, E. D., Iourin, O., Hockley, D. J., Kingsman, S. M., & Kingsman, A. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3474-3483.1997 · Cited by 86 · see citing works
Swingler, S., Gallay, P. A., Camaur, D., Song, J., Abo, A., & Trono, D. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4372-4377.1997 · Cited by 68 · see citing works
Dubay, J. W., Dubay, S. R., Shin, H.-J., & Hunter, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4675-4682.1995 · Cited by 85 · see citing works
Suomalainen, M., & Garoff, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4879-4889.1994 · Cited by 77 · see citing works
“It has been demonstrated that mutations in the matrix domain of the HIV-1 or the Mason-Pfizer monkey virus Gag precursor can impair inclusion of the respective viral spike proteins into virions (14, 43, 60), thereby strongly suggesting that core-spike interactions are needed for incorporation of spikes into virions.”
BackgroundHIV Genome-Wide Protein Associations: a Review of 30 Years of Research
Li, G., & Clercq, E. D. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00065-15 · Cited by 90 · see citing works
“The cytoplasmic tail of GP41 (GP41CT) not only enhances Env packaging during viral budding (77, 78) but also drives the rearrangements of Env prebundle structures during viral entry (79).”
BackgroundHIV Type 1 Gag as a Target for Antiviral Therapy
Waheed, A. A., & Freed, E. O. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0230 · Cited by 81 · see citing works
Virus-producing cells determine the host protein profiles of HIV-1 virion cores
Santos, S., Obukhov, Y., Nekhai, S. A., Bukrinsky, M., & Iordanskiy, S. (2012) · Retrovirology · doi:10.1186/1742-4690-9-65 · Cited by 78 · see citing works
Joshi, A., Ablan, S. D., Soheilian, F., Nagashima, K., & Freed, E. O. (2009) · Journal of Virology · doi:10.1128/jvi.00109-09 · Cited by 83 · see citing works
“Mutations in the MA domain of HIV-1 Gag have been shown to disrupt interactions with the viral Env glycoproteins, leading to defects in Env incorporation into virions (14, 20, 21, 74) or impaired gp120-gp41 associations (9).”
BackgroundVishwanathan, S., & Hunter, E. (2008) · Journal of Virology · doi:10.1128/jvi.00305-08 · Cited by 78 · see citing works
“In contrast, a structure where the three MPER regions interact in a stalk might well be disrupted by the mutations we have introduced into this region, allowing the MPER to interact instead with the membrane through its tryptophan residues, which in turn could alter the ability of gp41 to interact with assembling Gag…”
BackgroundWang, C.-T., Lai, H.-Y., & Li, J.-J. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7950-7959.1998 · Cited by 70 · see citing works
“Incorporation of Env into virus particles is also dependent on the integrity of the MA domain (9, 60).”
BackgroundMorikawa, Y., Zhang, W., HOCKLEY, D. J., Nermut, M. V., & Jones, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7659-7663.1998 · Cited by 75 · see citing works
“In the late stage of the viral life cycle, as part of the Pr55 Gag precursor, MA contributes sequences that are necessary for targeting the Gag precursor to the plasma membrane (3, 31, 39, 42) and for the incorporation, by the assembling virion, of the major surface glycoprotein gp160 (8, 11, 37, 38).”
BackgroundMarasco, W. (1995) · Immunotechnology · doi:10.1016/1380-2933(95)00001-1 · Cited by 75 · see citing works
Piller, S., Dubay, J., Derdeyn, C. A., & Hunter, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11717-11723.2000 · Cited by 74 · see citing works
“Several studies demonstrated that the HIV glycoproteins are incorporated into virus particles via an interaction with the Gag matrix (MA) domain (3, 9, 10, 13, 14, 24, 37).”
BackgroundDeml, L., Kratochwil, G., Osterrieder, N., Knüchel, R., Wolf, H., & Wagner, R. (1997) · Virology · doi:10.1006/viro.1997.8669 · Cited by 74
Massiah, M. A., Worthylake, D. K., Christensen, A. M., Sundquist, W. I., Hill, C. P., & Summers, M. F. (1996) · Protein Science · doi:10.1002/pro.5560051202 · Cited by 65 · see citing works
Davis, M., Jiang, J., Zhou, J.-J., Freed, E., & Aiken, C. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2405-2417.2006 · Cited by 71 · see citing works
“Mutations within the MA protein can impair HIV-1 envelope incorporation (15, 23, 83).”
BackgroundCarrière, C., Gay, B., Chazal, N., Morin, N., & Boulanger, P. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2366-2377.1995 · Cited by 62 · see citing works
“Considering the sequence of the baculovirus polyhedrin and the evolutionary divergence between the HIV and HSRV genomes, these results suggested a certain degree of tolerance for Gag particle assembly and release at the N terminus of the HIV-1 Gag precursor, in terms of MA length and amino acid sequence (11).”
BackgroundMethodIntracellular Transport of Retroviral Capsid Components
Kräusslich, H., & Welker, R. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80145-7_2 · Cited by 65 · see citing works
Monel, B., Beaumont, É., Vendrame, D., Schwartz, O., Brand, D., & Mammano, F. (2012) · Journal of Virology · doi:10.1128/jvi.06478-11 · Cited by 64 · see citing works
“following mutations: L8S plus S9R (MA-A), (16-18) (MA-B), W36S”
BackgroundMethodResultInfluentialSelf-citationBültmann, A., Muranyi, W., Seed, B., & Haas, J. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5263-5276.2001 · Cited by 68 · see citing works
“cytoplasmic domain appears to influence the incorporation of glycoproteins into virions (13, 15, 16, 22, 25, 28, 39, 72, 73).”
Gupta, K., Ott, D., Hope, T., Siliciano, R., & Boeke, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11811-11824.2000 · Cited by 68 · see citing works
“Matrix, a key component of the HIV-1 PIC, contributes to nuclear localization of the PIC and plays other crucial roles throughout the HIV-1 life cycle (6, 15, 24, 38, 50, 67).”
BackgroundLee, Y. M., Tang, X. B., Cimakasky, L. M., Hildreth, J. E. K., & Yu, X. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1443-1452.1997 · Cited by 56 · see citing works
“To date, most of the studies concerning HIV-1 Env and Gag interaction have been performed with cells such as COS or HeLa cells, which are not the primary target cells of HIV-1 infection in vivo (3, 10, 38).”
BackgroundMethodResultInfluentialNermut, M. V., HOCKLEY, D. J., Bron, P., Thomas, D., Zhang, W., & Jones, I. M. (1998) · Journal of Structural Biology · doi:10.1006/jsbi.1998.4024 · Cited by 64 · see citing works
Sakin, V., Hanne, J., Dunder, J., Anders-Össwein, M., Laketa, V., Nikić, I., Kräusslich, H., Lemke, E., & Müller, B. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.04.007 · Cited by 65 · see citing works
“HIV-1 Env incorporation into budding virions is mediated by the matrix domain of the Gag polyprotein (Dorfman et al., 1994; Tedbury and Freed, 2014; Yu et al., 1992).”
Christensen, A. M., Massiah, M. A., Turner, B. G., Sundquist, W. I., & Summers, M. F. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0700 · Cited by 59 · see citing works
Cleveland, S., McLain, L., Cheung, L., Jones, T., Hollier, M. J., & Dimmock, N. (2003) · Journal of General Virology · doi:10.1099/vir.0.18630-0 · Cited by 58
“, 2000) and interaction with the p17 MA protein (Bukrinskaya & Sharova, 1990; Cosson, 1996; Dorfman et al., 1994; Freed & Martin, 1995a, b, 1996; Mammano et al., 1995; Murakami & Freed, 2000a; Wyma et al., 2000).”
BackgroundRiffel, N., Harlos, K., Iourin, O., Rao, Z., Kingsman, A. J., Stuart, D. I., & Fry, E. E. (2002) · Structure · doi:10.1016/s0969-2126(02)00896-1 · Cited by 60 · see citing works
Retroviral Matrix Proteins: A Structural Perspective
Conte, M. R., & Matthews, S. (1998) · Virology · doi:10.1006/viro.1998.9206 · Cited by 61 · see citing works
Ghanam, R. H., Samal, A. B., Fernandez, T. F., & Saad, J. S. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00055 · Cited by 55 · see citing works
“(ii) Direct Gag–Env interaction: Genetic data revealed that the MA domain of Gag is required for Env incorporation (Yu et al., 1992; Dorfman et al., 1994; Freed and Martin, 1995, 1996).”
BackgroundHuman Immunodeficiency Virus Type 1 Matrix Protein Assembles on Membranes as a Hexamer
Alfadhli, A., Huseby, D. L., Kapit, E., Colman, D., & Barklis, E. (2006) · Journal of Virology · doi:10.1128/jvi.02122-06 · Cited by 53 · see citing works
“In this sort of arrangement, residues that have been identified genetically to interact with the HIV-1 transmembrane envelope protein (TM) and its cytoplasmic tail (12, 13, 16, 17, 59) are oriented towards threefold, clover leaf-shaped symmetric MyrMA lattice cage holes between hexamer units, rather than the hexamer h…”
BackgroundYuste, E., Johnson, W., Pavlakis, G., & Desrosiers, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12455-12463.2005 · Cited by 57 · see citing works
Ott, D. E., Chertova, E. N., Busch, L. K., Coren, L. V., Gagliardi, T. D., & Johnson, D. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.19-28.1999 · Cited by 50 · see citing works
“The results presented above show that the phenotype of the Y36S-L41P mutant is very similar to those of p17 mutants that have amino acid changes within the first 30 residues of MA (10, 11, 13, 62).”
BackgroundUpdate on the neutralisation of animal viruses
Dimmock, N. (1995) · Reviews in Medical Virology · doi:10.1002/rmv.1980050306 · Cited by 56 · see citing works
Maturation and assembly of retroviral glycoproteins.
Einfeld, D. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80145-7_5 · Cited by 56 · see citing works
Particle Size Determinants in the Human Immunodeficiency Virus Type 1 Gag Protein
Garnier, L., Ratner, L., Rovinski, B., Cao, S.-X., & Wills, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4667-4677.1998 · Cited by 55 · see citing works
Chazal, N., Gay, B., Carrière, C., Tournier, J., & Boulanger, P. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.365-375.1995 · Cited by 51 · see citing works
The frantic play of the concealed HIV envelope cytoplasmic tail
da Silva, E. S., Mulinge, M. M., & Perez-Bercoff, D. (2013) · Retrovirology · doi:10.1186/1742-4690-10-54 · Cited by 51 · see citing works
Levin, R., Mhashilkar, A. M., Dorfman, T., Bukovsky, A., Zani, C., Bagley, J., Hinkula, J., Niedrig, M., Albert, J., Wahrén, B., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401802 · Cited by 51 · see citing works
“Indeed, this epitope is not invariant even for the B Clade (57), and amino acid changes in this region are tolerated and generate infectious virus (21,58).”
BackgroundSelf-citation
- Authors
- Dorfman, T., Mammano, F., Haseltine, W. A., & Göttlinger, H. G.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1994-03
- Volume
- 68
- Issue
- 3
- Pages
- 1689-1696
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC236628
- OpenAlex
- W1557860493
- Cited by
- 288
- References
- 0
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 1 · 2022: 7 · 2021: 1 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 8 · 2013: 13 · 2012: 9
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA06516, P30CA006516)
- National Institute of Allergy and Infectious Diseases (AI29873, AI28691, P30AI028691)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- HIV-1 matrix protein, HIV-1 envelope glycoprotein, Gag precursor, gp120, gp41, visna virus, viral assembly, C-terminal domain, missense mutations, deletion mutations
- MeSH terms
- Cells, Cultured, DNA Mutational Analysis, Humans, Morphogenesis, Protein Binding, RNA, Viral, Structure-Activity Relationship, Viral Matrix Proteins, Virion, HIV-1, Gene Products, env
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review